Richard Smith

• T  +44 (0)20 7090 3386 (Direct line)
• E  richard.smith@slaughterandmay.com

• London 
• One Bunhill Row, London, EC1Y 8YY

Richard has a broad corporate and corporate finance practice with particular experience in public and private M&A and equity capital markets work. He has also developed specialist expertise in the utilities, insurance and banking sectors.

In 2010, Richard was seconded to the investment banking division legal team at Goldman Sachs International where he was involved in a large number of equity capital markets and M&A transactions across Europe, the Middle East and Africa.

Highlights include advising:

• GlaxoSmithKline on its three disposals of over-the-counter consumer healthcare brands to Aspen Pharmacare for £164 million and Omega Pharma for EUR 470 million in 2012, and to Prestige Brands for $660 million in 2011
• Aviva on the disposal of the RAC group to Carlyle
• Chi-X and its consortium shareholders on the acquisition of Chi-X by BATS
• Resolution on its takeover of Friends Provident
• HM Treasury on the Asset Protection Scheme and the lending commitments arranged with various banks